SCHEMBL3325464

SCHEMBL3325464

Cc1nc(-c2ccccc2Cl)n2c1nnc1ccc(N3CCOCC3)cc12

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 18/20 0.69
PDE10A Q9Y233 15/20 0.69
PDE6D O43924 4/20 0.69
PDE6A P16499 4/20 0.69
PDE6G P18545 4/20 0.69
PDE6B P35913 4/20 0.69
PDE6C P51160 4/20 0.69
PDE6H Q13956 4/20 0.69
PDE4A P27815 2/20 0.69
PDE4B Q07343 2/20 0.69
PDE4C Q08493 2/20 0.69
PDE4D Q08499 2/20 0.69
PDE3A Q14432 2/20 0.60
PDE1B Q01064 1/20 0.60
PDE7A Q13946 1/20 0.60
PDE3B Q13370 1/20 0.50
TP53 P04637 1/20 0.48
MAPK1 P28482 1/20 0.48
ESR2 Q92731 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3328972 0.90 PDE2A (0.56) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3325344 0.89 PDE2A (0.71) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3327084 0.89 PDE2A (0.62) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3326307 0.82 PDE2A (1.00) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL7908626 0.81 PDE2A (0.60) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL14361796 0.81 PDE2A (0.72) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3325943 0.79 PDE2A (0.65) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3325021 0.78 PDE2A (0.73) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3330230 0.78 PDE2A (0.82) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL3325828 0.78 PDE2A (0.56) PDE2APDE10APDE6DPDE6APDE6G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120763-A1 IMIDAZO[5,1-C][1,2,4]BENZOTRIAZINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES WYETH (US) 2010-05-13 US claimed
US-20100120763-A1 IMIDAZO[5,1-C][1,2,4]BENZOTRIAZINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES WYETH (US) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120763-A1 IMIDAZO[5,1-C][1,2,4]BENZOTRIAZINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES PDE2A, PDE5A, PDE3A PDE2A 1/4885PDE10A 13/4885PDE6D 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.